Sunday, November 1, 2026

Commodities & Natural Resources

2 articles

Gold at $4,200 Signals a Global Macro Fault Line: Precious Metals Surge as Industrial Commodities Falter

Gold at $4,200 Signals a Global Macro Fault Line: Precious Metals Surge as Industrial Commodities Falter

Gold futures have surged to $4,200 per ounce in 2026, driving a sharp divergence across global commodities markets as precious metals miners post record margins while base metals and energy producers face headwinds from slowing growth in China, Europe, and North America. The rally reflects a broad institutional rotation away from high-multiple equities and speculative assets toward hard-asset safe havens amid Federal Reserve rate cut expectations and softening real yields. For miners with Africa

ViaNews Editorial Team•
Canada's Blackwater Mine Set to Become One of World's Most Profitable Gold Operations as $1.1B Expansion Gets Green Light

Canada's Blackwater Mine Set to Become One of World's Most Profitable Gold Operations as $1.1B Expansion Gets Green Light

Artemis Gold has approved a $1.44 billion CAD expansion of its Blackwater Mine in British Columbia, targeting 500,000–525,000 ounces of annual gold production by 2029. At current gold prices near $4,200 per ounce, the mine's cost structure would generate margins exceeding 75% — extraordinary by any global mining standard. The project represents one of the most significant new gold supply additions in a stable jurisdiction in over a decade.

ViaNews Editorial Team•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com